4 Podcast Episodes
Joel R. Rosh, MD, FACG: Counterpoint: Clinical remission is all that matters while dealing with the new biologic therapy
Joel R. Rosh, MD, FACG: Counterpoint: Clinical remission is all that matters while dealing with the new biologic therapy
Webcast: Great Debates and Updates in Inflammatory Bowel Disease 2018
29 Aug 2018
•
11mins
Joel R. Rosh, MD, FACG: Role of diagnostic and therapeutic biomarkers in pediatric IBD
Joel R. Rosh, MD, FACG: Role of diagnostic and therapeutic biomarkers in pediatric IBD
Webcast: Great Debates and Updates in Inflammatory Bowel Disease 2018
29 Aug 2018
•
25mins
Joel R. Rosh, MD, FACG: Counterpoint: Clinical remission is all that matters while dealing with the new biologic therapy
Joel R. Rosh, MD, FACG: Counterpoint: Clinical remission is all that matters while dealing with the new biologic therapy
Webcast: Great Debates and Updates in Inflammatory Bowel Disease 2018
29 Aug 2018
•
11mins
Joel R. Rosh, MD, FACG: Role of diagnostic and therapeutic biomarkers in pediatric IBD
Joel R. Rosh, MD, FACG: Role of diagnostic and therapeutic biomarkers in pediatric IBD
Webcast: Great Debates and Updates in Inflammatory Bowel Disease 2018
29 Aug 2018
•
25mins